<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM XEROX CORPORATION'S 9-30-00 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-END> SEP-30-2000 <CASH> 154 <SECURITIES> 0 <RECEIVABLES> 16057 <ALLOWANCES> 571 <INVENTORY> 3108 <CURRENT-ASSETS> 12145 <PP&E> 5499 <DEPRECIATION> 3000 <TOTAL-ASSETS> 29283 <CURRENT-LIABILITIES> 7522 <BONDS> 17197 <PREFERRED-MANDATORY> 638 <PREFERRED> 659 <COMMON> 669 <OTHER-SE> 3382 <TOTAL-LIABILITY-AND-EQUITY> 29283 <SALES> 7192 <TOTAL-REVENUES> 13581 <CGS> 4266 <TOTAL-COSTS> 8287 <OTHER-EXPENSES> 5679 <LOSS-PROVISION> 316 <INTEREST-EXPENSE> 739 <INCOME-PRETAX> (385) <INCOME-TAX> (93) <INCOME-CONTINUING> (265) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (265) <EPS-BASIC> (0.44) <EPS-DILUTED> (0.44)